Citations refer to the original publication, not to a Scieee localized version.
Vidal, R. I. H. S. (2016). Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines. https://doi.org/10.34626/s54w-z040
Vidal, Rita Isabel Henriques Sério. Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines. 2016. https://doi.org/10.34626/s54w-z040.
Vidal, Rita Isabel Henriques Sério. Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines. 2016. https://doi.org/10.34626/s54w-z040.
Vidal, R. I. H. S. (2016) Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines. Available at: https://doi.org/10.34626/s54w-z040.
R. I. H. S. Vidal, “Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines,” 2016, doi: 10.34626/s54w-z040.
@misc{vidal2016antitumor,
author = {Vidal, Rita Isabel Henriques Sério},
title = {Antitumor activity of liposomal formulations oof bis-naphthalimide derivatives and erlotinib, in vitro study in pancreatic cancer cell lines},
year = {2016},
doi = {10.34626/s54w-z040},
url = {https://doi.org/10.34626/s54w-z040}
}
